TGAM
GBT

TBH Global Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

TBH Global Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,570
Closed -$225K – 181
2020
Q2 		$225K Buy
+3,570
New +$245K 0.09% 149

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBH Global Asset Management's GBT Position: Q3 2020 in Review

TBH Global Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 3,570 shares — an estimated $225K sold.

TBH Global Asset Management first reported a position in GBT in Q2 2020 and held it in 1 quarter. The position peaked at $225K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • TBH Global Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • TBH Global Asset Management sold 3,570 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $225K.
  • TBH Global Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • TBH Global Asset Management's Global Blood Therapeutics, Inc. position peaked at $225K in Q2 2020.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on TBH Global Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.